Dissemin is shutting down on January 1st, 2025

Published in

Springer, Netherlands Heart Journal, 12(17), p. 464-469, 2009

DOI: 10.1007/bf03086305

Springer, Netherlands Heart Journal

DOI: 10.1007/s12471-010-0004-1

Links

Tools

Export citation

Search in Google Scholar

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers

Journal article published in 2009 by J. T. Vehmeijer, I. Christiaans ORCID, I. M. van Langen, E. Birnie, G. J. Bonsel, E. M. A. Smets, A. A. M. Wilde
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background. Patients with hypertrophic cardiomyopathy (HCM) and HCM mutation carriers are at risk of sudden cardiac death (SCD). Both groups should therefore be subject to regular cardiological testing – including risk stratification for SCD – according to international guidelines. We evaluated Dutch cardiologists' knowledge of and adherence to international guidelines on risk stratification and prevention of SCD in mutation carriers with and without manifest HCM.